logo-loader

BIO President & CEO discusses the Trump administration's policies on drug pricing

Published: 12:01 12 Feb 2019 EST

BIO President & CEO Jim Greenwood sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

5 hours, 30 minutes ago